Acute Myeloid Leukemia with 11q23-abnormality in Relapse
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia with 11q23-abnormality in Relapse.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 trial evaluating temozolomide plus vorinostat in relapse/refractory acute myeloid leukemia with 11q23 abnormalities; study completed…